Wárlám-Rodenhuis CC - Search Results

1

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Schlich-Bakker KJ, ten Kroode HF, Wárlám-Rodenhuis CC, van den Bout J, Ausems MG. Schlich-Bakker KJ, et al. Among authors: warlam rodenhuis cc. Genet Med. 2007 Nov;9(11):766-77. doi: 10.1097/gim.0b013e318159a318. Genet Med. 2007. PMID: 18007146

2

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.

Wárlám-Rodenhuis CC, Koot VC, van der Luijt RB, Vasen HF, Ausems MG. Wárlám-Rodenhuis CC, et al. Eur J Cancer. 2005 Jul;41(10):1409-15. doi: 10.1016/j.ejca.2005.02.030. Eur J Cancer. 2005. PMID: 15955690

3

Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer.

Schlich-Bakker KJ, Wárlám-Rodenhuis CC, van Echtelt J, van den Bout J, Ausems MG, ten Kroode HF. Schlich-Bakker KJ, et al. Eur J Cancer. 2006 Nov;42(16):2722-8. doi: 10.1016/j.ejca.2006.05.032. Epub 2006 Sep 1. Eur J Cancer. 2006. PMID: 16949277

4

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.

Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, Wárlám-Rodenhuis CC, van den Bout J. Schlich-Bakker KJ, et al. Breast Cancer Res Treat. 2008 Jun;109(3):507-14. doi: 10.1007/s10549-007-9680-y. Epub 2007 Aug 3. Breast Cancer Res Treat. 2008. PMID: 17674198 Free PMC article.

5

Distress in couples approached for genetic counseling and BRCA1/2 testing during adjuvant radiotherapy.

Schlich-Bakker KJ, ten Kroode HF, Wárlám Rodenhuis CC, Ausems MG, van den Bout J. Schlich-Bakker KJ, et al. Among authors: warlam rodenhuis cc. Psychooncology. 2009 Sep;18(9):965-73. doi: 10.1002/pon.1446. Psychooncology. 2009. PMID: 19140177

6

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.

Van Riel E, Wárlám-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG. Van Riel E, et al. Among authors: warlam rodenhuis cc. Eur J Cancer Care (Engl). 2010 May;19(3):369-76. doi: 10.1111/j.1365-2354.2008.01065.x. Epub 2009 Jul 29. Eur J Cancer Care (Engl). 2010. PMID: 19659662

7

De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.

van der Luijt RB, van Zon PH, Jansen RP, van der Sijs-Bos CJ, Wárlám-Rodenhuis CC, Ausems MG. van der Luijt RB, et al. J Med Genet. 2001 Feb;38(2):102-5. doi: 10.1136/jmg.38.2.102. J Med Genet. 2001. PMID: 11158174 Free PMC article.

8

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.

Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Wárlám-Rodenhuis CC, Pierart M, Collette L. Bartelink H, et al. J Clin Oncol. 2007 Aug 1;25(22):3259-65. doi: 10.1200/JCO.2007.11.4991. Epub 2007 Jun 18. J Clin Oncol. 2007. PMID: 17577015 Clinical Trial.

9

The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.

Poortmans PM, Collette L, Bartelink H, Struikmans H, Van den Bogaert WF, Fourquet A, Jager JJ, Hoogenraad W, Müller RP, Dubois JB, Bolla M, Van Der Hulst M, Wárlám-Rodenhuis CC, Pierart M, Horiot JC; EORTC Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Among authors: warlam rodenhuis cc. Cancer Radiother. 2008 Nov;12(6-7):565-70. doi: 10.1016/j.canrad.2008.07.014. Epub 2008 Aug 28. Cancer Radiother. 2008. PMID: 18760649 Clinical Trial.

10

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.

Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras B, van Putten WL, Creutzberg CL. Nout RA, et al. Among authors: warlam rodenhuis cc. J Clin Oncol. 2011 May 1;29(13):1692-700. doi: 10.1200/JCO.2010.32.4590. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444867 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters